Old Web
English
Sign In
Acemap
>
authorDetail
>
Takuo Matsukawa
Takuo Matsukawa
Prostate cancer
Cancer research
Chemistry
castration resistant
Prostate
4
Papers
10
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer.
2021
in Vivo
Naohiro Fujimoto
Masaki Shiota
Takuo Matsukawa
Akinori Minato
Ikko Tomisaki
Rei Ohnishi
Masatoshi Eto
Show All
Source
Cite
Save
Citations (1)
Targeting Nrf2-antioxidant signaling reverses acquired cabazitaxel resistance in prostate cancer cells.
2021
Journal of Biochemistry
Satoshi Endo
Mina Kawai
Manami Hoshi
Jin Segawa
Mei Fujita
Takuo Matsukawa
Naohiro Fujimoto
Toshiyuki Matsunaga
Akira Ikari
Show All
Source
Cite
Save
Citations (1)
Development ofNovel AKR1C3 Inhibitors as New PotentialTreatment for Castration-Resistant Prostate Cancer
2020
Journal of Medicinal Chemistry
Satoshi Endo
Hiroaki Oguri
Jin Segawa
Mina Kawai
Dawei Hu
Shuang Xia
Takuya Okada
Katsumasa Irie
Shinya Fujii
Hiroaki Gouda
Kazuhiro Iguchi
Takuo Matsukawa
Naohiro Fujimoto
Toshiyuki Nakayama
Naoki Toyooka
Toshiyuki Matsunaga
Akira Ikari
Show All
Source
Cite
Save
Citations (0)
Development of novel AKR1C3 inhibitors as new potential treatment for castration-resistant prostate cancer.
2020
Journal of Medicinal Chemistry
Satoshi Endo
Hiroaki Oguri
Jin Segawa
Mina Kawai
Dawei Hu
Shuang Xia
Takuya Okada
Katsumasa Irie
Shinya Fujii
Hiroaki Gouda
Kazuhiro Iguchi
Takuo Matsukawa
Naohiro Fujimoto
Toshiyuki Nakayama
Naoki Toyooka
Toshiyuki Matsunaga
Akira Ikari
Show All
Source
Cite
Save
Citations (8)
1